A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for repurposing in dementia prevention.

A new study has found that a common class of medications could dramatically decrease the risk of developing the neurodegenerative disorder.

ABC News' Dr. Tara Narula breaks down a new study suggesting that a common HIV medication may significantly reduce the risk ...

Nucleoside reverse transcriptase inhibitors (NRTIs) are used to prevent HIV and hepatitis B from replicating and spreading ...

As the federal government cuts funding for HIV and AIDS research, Illinois is trying to make HIV prevention meds more ...

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

The Trump administration’s dismantling of USAID has put more than 8,000 health workers in South Africa’s national HIV program ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

“Our results suggest that taking these drugs could prevent approximately 1 million new cases of Alzheimer’s disease every year.” NRTIs, or nucleoside reverse transcriptase inhibitors, are used to ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

"Our results suggest that taking these drugs could prevent approximately 1 million new cases of Alzheimer's disease every ...

The human immunodeficiency virus (HIV) market across the seven major markets (7MM), comprising the US, France, Germany, Italy ...